Rob Kessels
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Ethics of Backfilling in Early-Phase Oncology Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2026
A Knowledge Base of Designs and Statistical Methods for Adaptive Clinical Dose-Finding Trials.
Journal: Pharmaceutical statistics
Published: October 06, 2025
Patient preference trials in oncology: a scoping review and recommendations on reporting.
Journal: Journal of clinical epidemiology
Published: January 31, 2025
PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients.
Journal: European urology open science
Published: September 19, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.
Journal: Journal for immunotherapy of cancer
Published: February 26, 2024
Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma.
Journal: Clinical and translational radiation oncology
Published: October 31, 2023
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Oncology
Published: October 30, 2023
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study).
Journal: Clinical and translational radiation oncology
Published: July 11, 2023
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).
Journal: JTO clinical and research reports
Published: March 16, 2023
Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.
Journal: The New England journal of medicine
Published: March 01, 2023
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: December 08, 2022
Last Updated: 09/26/2026